With the WHO’s announcement that it has officially declared an H1N1 flu pandemic – the first global flu epidemic in 41 years – swine flu has Wall Street’s full attention once again. Disease fears had mostly faded from the mind of many investors, despite numerous warnings that we weren’t yet fully in the clear. While the WHO’s announcement is, on the whole, bad news for equity markets, I wrote yesterday that pharmaceutical and healthcare ETFs may stand to benefit from prolonged fears over an outbreak. As with most major developments, there’s another side to the coin. Here’s a look at four ETFs that could face downward pressure in the wake of the pandemic declaration: [click to continue…]
{ Comments on this entry are closed }
